Gastrointestinal Cancer: Pathogenesis

Pathogenesis of Colorectal Cancer: Sporadic (Nonhereditary) Colorectal Cancer is detected through screening procedures or when the patient presents with symptoms. Screening is important for prevention and should be a part of routine care for adults over the age of 50 who are at low-risk. High-risk individuals (those who are with previous colon cancer, those who have family history of colon cancer, and those who have inflammatory bowel disease or history of colorectal polyps) require careful follow-up. Major advances have been made in our understanding of molecular events leading to the formation of adenomatous polyps and cancer most of the colorectal cancers are sporadic.

Despite a few breakthroughs in therapy for advanced disease in the recent years, the overall prognosis for the majority of patients with pancreatic cancer is rather dismal, and therefore, more effective treatment options are being desperately sought. The practical goals of management are to improve the cure rates for patients with resectable disease, achieve a higher conversion rate of locally advanced tumor into potentially resectable disease, and finally, prolong the overall survival for those who develop metastatic disease. Our understanding of the complex genetic alterations, the implicated molecular pathways, and the role of desmoplastic stroma in pancreatic cancer tumorigenesis has increased several folds in the recent years. This review will summarize the existing treatment approaches for this devastating disease and also discuss the promising therapeutic approaches that are currently in different stages of clinical development. 

  • Pancreatic and Colorectal Cancer practice
  • Pancreactic and Colorectal Cancer practice management
  • Pancreactic and Colorectal Cancer practice management Software

Related Conference of Gastrointestinal Cancer: Pathogenesis

October 26-28, 2017

9th International Conference on Biomarkers

Osaka,Japan
November 06-08, 2017

2nd International Congress on Epigenetics & Chromatin

Frankfurt, Germany (H4 Hotel Frankfurt Messe)
November 09-10, 2017

10th World Hematology and Oncology Congress

Vienna, Austria
November 20-22, 2017

14th Asia Pacific
Oncologists Annual Meeting

Melbourne, Australia
November 27-28, 2017

26th World Cancer Convention

Dubai, UAE
November 27- 28, 2017

International Conference on Cancer Diagnostics

Dubai, UAE
December 07-08, 2017

9th World Biomarkers Congress

Madrid, Spain
Oct 15-16, 2018

Cell Biology & Cancer Research

Toronto, Canada
March 12-14, 2018

Global Summit on Oncology & Cancer

Singapore
April 16-17, 2018

Global Meeting on Oncology and Radiology

Tokyo,Japan
May 24-25, 2018

22nd Global Annual Oncologists Meeting

Osaka, Japan
July 18-19, 2018

4th Annual Conference on Preventive Oncology

Atlanta, USA
July 18-19, 2018

4th Annual Conference on Gynecologic Oncology

Atlanta, USA
August 09-10, 2018

28th Euro Congress on Cancer Science & Therapy

Madrid, Spain

World Cancer Meeting

Osaka, Japan
September 20-21, 2018

3rd Oncologist & Cancer Diagnostics Conference 2018

Berlin, Germany
October 03-04, 2018

2nd International Conference on Cancer Biology and Drug Delivery

Los Angeles, California, USA
October 26-27, 2018

International Conference on Robotic Oncology

Osaka, Japan
July 11-12, 2018

Experts Meet On Cancer Therapy 2018

Sydney, Australia

Gastrointestinal Cancer: Pathogenesis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in